Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.

British journal of haematology - 1 Mar 2012

Miles Rodney R, Arnold Staci, Cairo Mitchell S

Abstract excerpt

Burkitt lymphoma/leukaemia is the most common (40%) form of non-Hodgkin lymphoma that occurs in children and adolescents. The prognosis of advanced (disseminated) Burkitt lymphoma/leukaemia in children and adolescents three decades ago had a 5-year event-free survival (EFS) of <40%, and required combination chemotherapy and radiation therapy over a 1-2 year period. Currently, the prognosis for the same advanced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Burkitt Lymphoma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Aberrations

Share to Comparative Genomic Hybridization

Share to Diagnosis, Differential

Share to Immunophenotyping

Share to Immunotherapy

Share to Neoplasm, Residual

Source

Identifiers

PMID: 22260323
DOI: 10.1111/j.1365-2141.2011.09024.x

Genes

EFS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Risk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.PMID 22260323Read ↗

The treatment of Burkitt lymphoma in adults.Semantic proximity Read ↗

Burkitt lymphoma: bridging the gap between advances in molecular biology and therapySemantic proximity Read ↗

Burkitt's lymphoma: molecular pathogenesis and treatment.Semantic proximity Read ↗

Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.Semantic proximity Read ↗

Clinical Features and Treatment Strategies of Precursor B-cell Lymphoblastic Leukemia with C-myC Rearrangement in ChildhoodSemantic proximity Read ↗

Burkitt Lymphoma and MYCSemantic proximity Read ↗

Clinical Features and Treatment Strategies of Precursor B-cell Lymphoblastic Leukemia with C-myC Rearrangement in ChildhoodSemantic proximity Read ↗

Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group reportSemantic proximity Read ↗

Update on Burkitt Lymphoma.Semantic proximity Read ↗

Double hit lymphoma: How do we define it and how do we treat it?Semantic proximity Read ↗

[Childhood acute lymphoblastic leukemia; pathophysiology and treatment strategy].Semantic proximity Read ↗

Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.